Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

University of Alberta: Clinical Trials & FDA Approval Profile

University of Alberta (Global / Institutional) sponsors 75 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 31 active protocols (23 recruiting now), 28 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)21.3%
Median Closed Enrollment vs National (145 pts)42 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for University of Alberta
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)75
Active Pipeline (Recruiting Now)31 (23)
Completed vs Stopped Early28 / 16 (21.3%)
Median Closed Actual Enrollment42 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With University of Alberta
Hospital Research SiteLocationShared Protocols
University of AlbertaEdmonton, Alberta25
University of Alberta HospitalEdmonton, Alberta21
University of CalgaryCalgary, Alberta3

Explore interactive annual charts and M&A subsidiary rollups in the University of Alberta Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI